Notably, overexpression of miR-19b-3p in AMEXO enhanced their therapeutic effects in inhibiting Ang II-induced AAA formation and aortic senescence, and reduced the protein level of MST4, p-ERK and p-Drp1 in the AAA aortic tissue of mice. The gene discussed is STK26; the disease is triple-A syndrome.